Title: Identification and characterization of potential impurities of rabeprazole sodium.
Journal: Journal of pharmaceutical and biomedical analysis 20070312
1083100-26-8
1246818-79-0
1083100-27-9
1114543-47-3
1346599-85-6
1346599-69-6
881189-62-4 | 3-(3-Fluoro-4-methylphenyl)propanoic acid | AA00GY3F | MFCD09025364
907208-90-6 | 1-(5-Fluoropyridin-2-yl)piperazine | AA00GYK5 | MFCD11656371
88818-90-0 | 5-Amino-6-methylpyridin-2(1h)-one | AA00GZYU | MFCD07375118
926247-39-4 | 4-(Ethylsulfonamido)butanoic acid | AA00H09W | MFCD08443567
929617-30-1 | 5-Bromo-3-methyl-1h-pyrazolo[3,4-c]pyridine | AA00H0V3 | MFCD12024520
887707-95-1 | Boc-thr(fmoc-val)-oh | AA00H104 | MFCD11974993
911060-83-8 | Ethyl 1-(aminomethyl)cyclobutanecarboxylate | AA00H1GF | MFCD11858336
874-64-6 | N-Cyclopropylcyclohexanamine hydrochloride | AA00H1TZ | MFCD11696449
868692-81-3 | 4-Bromo-2-iodo-5-(trifluoromethyl)aniline | AA00H1XW | MFCD13193085
908269-56-7 | 2-(2-Amino-1,3-thiazol-5-yl)propan-2-ol | AA00H2BQ | MFCD20725999